Global Immunomodulator Market Valuation Set to Total a Staggering US$ 178 Billion by 2034, Spurred by Spike in Chronic Disease Prevalence

The immunomodulator market is positioned for robust growth driven by the rising burden of chronic diseases like cancer and autoimmune disorders. These conditions fuel the need for effective treatments, which immunomodulators can provide. Early detection through improved diagnostics…